Clinical Trials Directory

Trials / Unknown

UnknownNCT03769922

Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease

The MESOCOLIC Trial: Mesenteric Excision Surgery or Conservative Limited Resection in Crohn's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The study evaluates whether there is a reduction in the rate of postoperative progression of the disease following extensive mesenteric excision (EME), when compared to that of limited mesenteric excision (LME), in patients undergoing ileocolic resection for Crohn's disease. Half of participants will receive EME, while the other half will receive LME.

Detailed description

EME and LME are the two surgical procedures which are commonly used in the treatment of Crohn's disease. However, the areas of the mesenteric tissue resected are different. EME means that the mesentery is resected avoiding the root region, i.e. 1 cm from the root of ileocolic artery and vein. LME represents that the mesentery is retained, i.e. "Close shave" or 3 cm from the border of bowel (using whatever approach - clips, or haemostatic vessel sealing device).

Conditions

Interventions

TypeNameDescription
PROCEDUREExtensive mesenteric resectionThe mesentery is resected avoiding the root region.
PROCEDURELimited mesenteric excisionThe mesentery is retained.

Timeline

Start date
2019-02-18
Primary completion
2024-01-01
Completion
2025-01-01
First posted
2018-12-10
Last updated
2019-02-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03769922. Inclusion in this directory is not an endorsement.